Kymera Therapeutics, Inc.
KYMR
Classement en actions
#2180
Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to... Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins. The company's pipeline features several programs, including the IRAK4 program, currently in Phase I clinical trials, which targets various immunology-inflammation disorders such as hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, generalized pustular psoriasis, and rheumatoid arthritis. Additionally, Kymera is advancing its IRAKIMiD program, designed to address MYD88-mutated diffuse large B cell lymphoma. Other key programs include the STAT3 program, focused on hematological malignancies, solid tumors, autoimmune diseases, and fibrosis, as well as the MDM2 program, which is also aimed at hematological malignancies and solid tumors. The company was founded in 2015 and maintains its headquarters in Watertown, Massachusetts.
Prix de l'action
$114.06
Dernière synchronisation: 2026-10-20
Capitalisation boursière
$9.38B
Changement (1 jour)
5.54%
Changement (1 an)
95.57%
Pays
US
Échange Kymera Therapeutics, Inc. (KYMR)
Catégorie
Healthcare
Nombre d'actions en circulation pour Kymera Therapeutics, Inc. (KYMR)
Nombre d'actions en circulation au June 2026: 98.18M
Selon les derniers rapports financiers et le cours de l'action de Kymera Therapeutics, Inc., le nombre actuel d'actions en circulation est de 98.18M. À la fin de December 2023, l'entreprise avait 58.37M actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de Kymera Therapeutics, Inc. (KYMR) de 2018 à 2026
Actions en circulation à la fin de chaque année
| Année | Actions en circulation | Changez |
|---|---|---|
| 2026 (TTM) | 98.18M | 30.83% |
| 2024 | 75.04M | 28.58% |
| 2023 | 58.37M | 8.22% |
| 2022 | 53.93M | 12.39% |
| 2021 | 47.99M | 7.70% |
| 2020 | 44.56M | 0.06% |
| 2019 | 44.53M | 0.00% |
| 2018 | 44.53M | 0.00% |
Actions en circulation pour des entreprises similaires ou concurrentes
| Entreprise | Actions en circulation | Différence | Pays |
|---|---|---|---|
| 253.90M | 158.61% |
US
|
|
| 396.00M | 303.35% |
US
|
|
| 478.91M | 387.80% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -36.66% |
NL
|
